Skip to main content
. 2021 Oct 28;7(11):916. doi: 10.3390/jof7110916
Criteria for Appropriateness (n = Applicable for Assessment) n (%)
1. Indications (39) 39 (100)
2. Choice of antifungal (39) 38 (97.4)
3. Dose of antifungal (37) 37 (94.8)
4. Microbiological appropriateness (18) 18 (100)
5. Intravenous-oral switch (11) 7 (63.6)
6. Treatment duration (21) 19 (90.5)